AtriCure Quarterly Cash Flow Statement
NASDAQ: ATRCHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
AtriCure free cash flow
In the quarter ended Jun 30, 2026, AtriCure generated $22.2 million of operating cash flow and spent $3.8 million on capital expenditures. That left free cash flow of $18.4 million, a free-cash-flow margin of 12.0% of revenue. Free cash flow was down 2.8% from the prior year's $19.0 million.
Summary generated from market data by MetaCap's automated system. Methodology
AtriCure cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 8.96M | 108.00K | 1.76M | -267.00K | -6.19M | -6.75M | -15.57M | -7.85M | -8.01M | -13.27M | -9.79M | -9.05M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 2.92M | 2.89M | 3.00M | 3.06M | 3.06M | 2.97M | 2.94M | 3.04M | 2.64M | 2.59M | 2.48M | 2.41M |
| Stock-Based Compensation | 12.31M | 11.27M | 11.26M | 12.42M | 11.37M | 9.63M | 10.38M | 10.36M | 10.39M | 9.27M | 9.31M | 8.66M |
| Change in Working Capital | -4.74M | -15.72M | -870.00K | 9.84M | 4.42M | -15.22M | -5.04M | 10.26M | -1.86M | -19.73M | 2.55M | -3.44M |
| Operating Cash Flow | 22.19M | -4.00M | 20.03M | 26.72M | 21.62M | -11.03M | 5.84M | 20.00M | 7.38M | -21.02M | 4.03M | 1.52M |
| Capital Expenditures | -3.77M | -3.85M | -1.60M | -2.60M | -2.66M | -2.18M | -2.69M | -3.61M | -2.38M | -2.77M | -2.79M | -3.63M |
| Investing Cash Flow | -3.77M | -3.85M | -2.60M | -2.60M | -7.66M | -1.68M | -14.69M | 4.39M | 30.89M | 9.64M | -2.79M | 11.87M |
| Debt Issued | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 61.21M | 0 | 0 |
| Financing Cash Flow | 3.26M | -13.26M | 2.10M | 5.98M | 3.42M | -10.32M | 1.74M | -333.00K | 2.85M | -7.86M | 2.36M | 132.00K |
| Net Change in Cash | 21.62M | -21.26M | 19.56M | 30.07M | 17.91M | -22.84M | -7.61M | 24.30M | 41.07M | -19.34M | 3.71M | 13.36M |
| Free Cash Flow | 18.43M | -7.85M | 18.43M | 24.11M | 18.95M | -13.21M | 3.14M | 16.40M | 5.00M | -23.79M | 1.24M | -2.11M |
This table shows 12 quarterly periods of AtriCure's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ATRC's reporting calendar. What is a cash flow statement?